Church & Dwight Co., Inc. (NYSE:CHD) Shares Purchased by Axa S.A.

AXA S.A. increased its stake in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 12.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 301,905 shares of the company's stock after acquiring an additional 34,075 shares during the period. AXA S.A. owned about 0.12% of Church & Dwight worth $31,612,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. YANKCOM Partnership bought a new position in shares of Church & Dwight in the fourth quarter worth approximately $25,000. Versant Capital Management Inc increased its holdings in Church & Dwight by 224.4% during the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company's stock valued at $28,000 after purchasing an additional 184 shares during the period. Strategic Financial Concepts LLC purchased a new stake in Church & Dwight in the 4th quarter worth approximately $39,000. Bernard Wealth Management Corp. purchased a new position in shares of Church & Dwight during the fourth quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust purchased a new stake in Church & Dwight in the fourth quarter worth $43,000. 86.60% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CHD has been the subject of several research analyst reports. Oppenheimer lowered their price objective on shares of Church & Dwight from $120.00 to $115.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Bank of America raised Church & Dwight from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $112.00 to $125.00 in a research report on Tuesday, April 15th. Barclays lowered their price objective on Church & Dwight from $94.00 to $84.00 and set an "underweight" rating on the stock in a research report on Friday, May 2nd. UBS Group reduced their price objective on Church & Dwight from $110.00 to $102.00 and set a "neutral" rating for the company in a research report on Friday, May 2nd. Finally, Royal Bank of Canada reduced their price target on shares of Church & Dwight from $105.00 to $100.00 and set a "sector perform" rating for the company in a research report on Friday, May 2nd. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Church & Dwight has a consensus rating of "Hold" and an average price target of $109.13.

Church & Dwight Trading Down 0.0 %

CHD traded down $0.02 during trading on Wednesday, reaching $92.05. The company had a trading volume of 2,089,255 shares, compared to its average volume of 1,583,481. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. Church & Dwight Co., Inc. has a 52 week low of $91.08 and a 52 week high of $116.46. The stock has a market cap of $22.66 billion, a P/E ratio of 38.84, a PEG ratio of 3.32 and a beta of 0.55. The business has a 50 day simple moving average of $105.19 and a 200-day simple moving average of $105.75.

Church & Dwight (NYSE:CHD - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.52 billion. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. The firm's revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.96 EPS. On average, equities analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Thursday, May 15th will be given a dividend of $0.295 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.18 annualized dividend and a dividend yield of 1.28%. Church & Dwight's dividend payout ratio (DPR) is 50.64%.

Insider Transactions at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of Church & Dwight stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the completion of the sale, the executive vice president now directly owns 10,497 shares in the company, valued at approximately $1,217,442.06. The trade was a 83.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Rene Hemsey sold 11,060 shares of the company's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total value of $1,216,378.80. Following the completion of the sale, the executive vice president now owns 6,437 shares in the company, valued at $707,941.26. The trade was a 63.21 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 65,570 shares of company stock valued at $7,538,449. 1.20% of the stock is currently owned by company insiders.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.